4th Quarter - Amendment

TAUZIN CONSULTANTS, LLC for SCILEX HOLDING COMPANY

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 14, 2021 $50,000 Replaced
4th Quarter - Amendment (this page) Jan 15, 2021 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to fair competition, the generic drug market, drug costs, pain management, and non-opioid alternatives. Also issues related to COVID-19.

LobbyistCovered position, as disclosed
MICHAEL DAVID MEIROVITZ —
MIMI SIMONEAUX KNEUER Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin
THOMAS TAUZIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to fair competition, the generic drug market, drug costs, pain management, and non-opioid alternatives. Issues related to COVID-19.

LobbyistCovered position, as disclosed
MICHAEL DAVID MEIROVITZ —
MIMI SIMONEAUX KNEUER Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin
THOMAS TAUZIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Affiliated organisations

OrganisationLocation
SCILEX PHARMACUETICALS San Diego, CA, US
SEMNUR PHARMACEUTICALS INC. Mountain View, CA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.